Fifth Third Bancorp
RCUS icon

Fifth Third Bancorp’s Arcus Biosciences RCUS Stock Holding History

Fifth Third Bancorp’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$436K Buy
20,171
+18,660
+1,235% +$403K ﹤0.01% 2110
2025
Q4 		$36K Buy
1,511
+24
+2% +$490 ﹤0.01% 1619
2025
Q3 		$20.2K Buy
1,487
+533
+56% +$5.54K ﹤0.01% 1884
2025
Q2 		$7.77K Buy
954
+43
+5% +$367 ﹤0.01% 2092
2025
Q1 		$7.15K Buy
911
+625
+219% +$7.25K ﹤0.01% 2112
2024
Q4 		$4.26K Sell
286
-180
-39% -$2.94K ﹤0.01% 2196
2024
Q3 		$7.13K Buy
466
+24
+5% +$378 ﹤0.01% 2095
2024
Q2 		$6.73K Buy
442
+305
+223% +$4.92K ﹤0.01% 2044
2024
Q1 		$2.59K Buy
137
+114
+496% +$1.97K ﹤0.01% 2191
2023
Q4 		$439 Sell
23
-31
-57% -$495 ﹤0.01% 2455
2023
Q3 		$969 Sell
54
-150
-74% -$3.01K ﹤0.01% 2461
2023
Q2 		$4.14K Buy
+204
New +$3.88K ﹤0.01% 2257
2023
Q1 		– Sell
-665
Closed -$13.8K – 2824
2022
Q4 		$13.8K Hold
665
– – ﹤0.01% 1833
2022
Q3 		$17K Hold
665
– – ﹤0.01% 1761
2022
Q2 		$17K Buy
+665
New +$16.3K ﹤0.01% 1802

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Fifth Third Bancorp's RCUS Position: Q1 2026 in Review

Fifth Third Bancorp increased its Arcus Biosciences (RCUS) stake by 1,235% in Q1 2026, buying an estimated $403K and bringing the position to 20,171 shares worth $436K. The position accounts for ﹤0.01% of the portfolio, ranked #2110.

Fifth Third Bancorp first reported a position in RCUS in Q2 2022 and has held it in 15 quarters since. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Fifth Third Bancorp held 20,171 shares of Arcus Biosciences worth $436K as of Q1 2026.
  • Fifth Third Bancorp bought 18,660 Arcus Biosciences shares in Q1 2026, an estimated $403K.
  • Arcus Biosciences made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #2110 holding.
  • Fifth Third Bancorp first reported a position in Arcus Biosciences in Q2 2022 and has held it in 15 quarters since.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.